JRC Publications Repository

JRC Publications Repository >

Browsing by Author APOSTOLIDIS Christos

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 21 to 40 of 147
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2007Character of 5f states in the Pu-Am System from Magnetic Susceptibility, Electrical Resistivity, and Photoelectron Spectroscopy MeasurementsBACLET N.; DORMEVAL M.; HAVELA Ladislav; FOURNIER J.m.; VALOT C.; WASTIN FRANCK; GOUDER THOMAS; COLINEAU ERIC; WALKER CLIVE; BREMIER STEPHAN, et alArticles in Journals
2011Characterization and classification of uranium ore concentrates (yellow cakes) using infrared spectrometryVARGA Zsolt; OEZTUERK B.; MEPPEN Manuela; MAYER Klaus; WALLENIUS Maria; APOSTOLIDIS ChristosArticles in Journals
2011Characterization and classification of uranium ore concentrates (yellow cakes) using infrared spectrometryVARGA Zsolt; ÖZTÜRK Betul; MEPPEN Manuela; MAYER Klaus; WALLENIUS Maria; APOSTOLIDIS ChristosArticles in Journals
1998Chloro-Lanthanide and Plutonium Complexes Containing the Hydrotris (3,5-dimethylpyrazol-1-yl)borate Ligand: the Crystal and Molecular Structures of (PrCl(mu-Cl)TpMe2(3,5-Me2pzH))2 and YbCl2TpMe2(THF).APOSTOLIDIS Christos; CARVALHO A.; DOMINGOS A.; KANELLAKOPOULOS Basil; MAIER Ralph; MARQUES N.; PIRES DE MATOS A.; REBIZANT JeanArticles in Journals
2003Comparison of the Radiotoxicity of two Alpha-Particle-Emitting Immunoconjugates, Terbium-149 and Bismut-213, Directed against a Tumor-Specific, Exon 9 Deleted (d99) E-Cadherin Adhesion Protein.MIEDERER M.; SEIDL C.; BEYER G.; CHARLTON D.e.; VRANJES-DURIC S.; COMOR J.j.; HUBER Roswitha; NIKULA T.; APOSTOLIDIS Christos; SCHUMACHER C., et alArticles in Journals
2006Control of Prostate Cancer Spheroid Growth Using (213)Bi-labeled Multiple Targeted Alpha RadioimmunoconjugatesWANG J.; RIZVI S.m.a.; MADIGAN C.; COZZI P.j.; POWER C.a.; QU C.f.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; RUSSEL P.j.; ALLEN B.j., et alArticles in Journals
2013Controlled Synthesis of Thorium and Uranium Oxide NanocrystalsHUDRY DAMIEN; APOSTOLIDIS Christos; WALTER OLAF; GOUDER Thomas; COURTOIS Eglantine; KÜBEL Christian; MEYER D.Articles in Journals
2009Cross Sections of the Reaction 231Pa(d,3n)230U for Production of 230U/226Th for Targeted Alpha TherapyMORGENSTERN Alfred; LEBEDA O.; STURSA J.; CAPOTE R.; SIN M.; BRUCHERTSEIFER Frank; ZIELINSKA Barbara; APOSTOLIDIS ChristosArticles in Journals
2008Cross-sections of the Reaction 232Th(p,3n)230Pa for Production of 230U for Targeted Alpha TherapyMORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; CAPOTE R.; GOUDER Thomas; SIMONELLI Federica; SIN M.; ABBAS KamelArticles in Journals
1997Crystallization and X-Ray Structures of /NaYb(c5h5)3/ and Yb(C5H5)2APOSTOLIDIS Christos; DEACON Glen; DORNBERGER Ernst; EDELMANN F.t.; MAC KINNON P.; STALKE D.Articles in Journals
2005Cyclotron Production of Ac-225 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; ABBAS KAMEL; MOELLENBECK J.; MORGENSTERN ALFREDArticles in Journals
2005Cyclotron Production of Ac-225 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; MOELLENBECK J.; MORGENSTERN ALFRED; ABBAS KAMELArticles in Journals
2005Cyclotron Production of Ac-225 for Targeted Alpha Therapy.APOSTOLIDIS Christos; MOLINET Roger; MC GINLEY J.; MOELLENBECK J.; MORGENSTERN A.Articles in Journals
2005Cyclotron Production of Ac-225 for Targeted alpha Therapy.APOSTOLIDIS Christos; MOLINET Roger; MC GINLEY J.; ABBAS Kamel; MOLLENBECK J.Articles in Journals
2008The Cytokinesis-Block Micronucleus Assay as a Biological Dosimeter for Targeted Alpha TherapySONG E.; RIZVI S.; QU C. F.; RAJA C.; YUEN J.; LI Y.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J.Articles in Journals
1996Cytotoxicity of 213Bi- and 225Ac-ImmunoconjugatesKASPERSEN F.m.; BOS E.; DOORNMALEN A.v.; APOSTOLIDIS ChristosArticles in Journals
2006Cytotoxicity of PAI2, C595 and Herceptin Vectors Labeled with the Alpha-Emitting Radioisotope Bismuth-213 for Ovarian Cancer Cell Monolayers and ClustersSONG Y.j.; QU C.f.; RIZVI S.m.a.; LI Y.; ROBERTSON G.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; PERKINS A.c.; ALLEN Barry J.Articles in Journals
2000Cytotoxicity of the alpha Emitter 213-Bi Coupled to a Specific Antobody.MIEDERER M.; NIKULA T.; BRANDES K.; HANDSCHUH G.; ADAM C.; SCHUMACHER C.; APOSTOLIDIS Christos; BRECHBIEL M.; SCHMID E.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2013Decay data measurements on 213Bi using recoil atomsMAROULI MARIA; SULIMAN GABRIEL; POMME Stefaan; VAN AMMEL Raf; JOBBAGY VIKTOR; STROH HEIKO; DIKMEN H.; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank, et alArticles in Journals
2002Determination of the Age of Highly Enriched Uranium.WALLENIUS Maria; MORGENSTERN A.; APOSTOLIDIS Christos; MAYER KlausArticles in Journals
Showing results 21 to 40 of 147

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top